Ascentage’s drug shows potential to treat Covid-19 in preclinical study
Olverembatinib showed increased Omicron-NTD-mediated cytokine release suppression compared with ponatinib and baricitinib.
Impact of Chinas Zero COVID lockdowns
Decoding the Covid-19 connection with diabetes
FDA declines to grant EUA for antidepressant to treat Covid-19
Covid-19 patent lawsuits: Will vaccine producers have to pay the bill?
Sound Pharmaceuticals receives NIH grant for Covid-19 therapy development
FDA grants approval for Lilly-Incyte’s Covid-19 treatment
COVID-19 health concern declines in April: Poll
Leverage existing Covid-19 networks to tackle paediatric hepatitis outbreak
